Celcuity announced that its Phase III Viktoria-1 clinical trial has successfully achieved the primary endpoint in the Pik3CA mutant patient cohort.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Experimental data show that this cohort of patients achieved a clinically significant improvement in progression-free survival.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Clarity Act prohibits stablecoin yield products similar to bank deposits
AiCoin•2026/05/01 21:36
Trending news
MoreReport: New Disney CEO explores a "super app" covering streaming and theme parks
According to a recent filing submitted to the U.S. Securities and Exchange Commission, Michael E. Fortin, Chief Financial Officer of Natural Alternatives International, has officially submitted his resignation, which will take effect on May 15, 2026.
Crypto prices
MoreBitcoin
BTC
$78,237.7
+2.57%
Ethereum
ETH
$2,294.34
+1.62%
Tether USDt
USDT
$0.9998
+0.01%
XRP
XRP
$1.39
+1.66%
BNB
BNB
$617.2
+0.21%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$83.71
+1.01%
TRON
TRX
$0.3271
+0.17%
Dogecoin
DOGE
$0.1093
+2.77%
Hyperliquid
HYPE
$41.02
+3.72%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now